Li, Q., Yu, Q., Ju, J., You, T., Yan, Z., Nan, X., . . . Zhou, J. E. (2017). Long-Circulating Liposomal Delivery System Targeting at PDGFR-β Enhances the Therapeutic Effect of IFN-α on Hepatic Fibrosis. Current pharmaceutical design, 23(20), 3034. https://doi.org/10.2174/1381612822666161208144953
Chicago Style (17th ed.) CitationLi, Qinghua, Qi Yu, Jing Ju, Tiangeng You, Zhiqiang Yan, Xiangli Nan, Jie Zhong, and Jing E. Zhou. "Long-Circulating Liposomal Delivery System Targeting at PDGFR-β Enhances the Therapeutic Effect of IFN-α on Hepatic Fibrosis." Current Pharmaceutical Design 23, no. 20 (2017): 3034. https://doi.org/10.2174/1381612822666161208144953.
MLA (9th ed.) CitationLi, Qinghua, et al. "Long-Circulating Liposomal Delivery System Targeting at PDGFR-β Enhances the Therapeutic Effect of IFN-α on Hepatic Fibrosis." Current Pharmaceutical Design, vol. 23, no. 20, 2017, p. 3034, https://doi.org/10.2174/1381612822666161208144953.